slotkoers
Korea S.E.
00:00:00 20-05-2024
|
Variatie 5 dagen
|
Verschil t.o.v. 1 jan (%)
|
11.200
KRW
|
+10,34%
|
|
+4,48%
|
+65,44%
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Marktkapitalisatie
1 |
188.609
|
142.243
|
364.645
|
293.575
|
255.403
|
144.945
|
Bedrijfswaarde
1 |
149.475
|
108.337
|
291.318
|
252.467
|
271.246
|
175.009
|
K/w-verhouding
|
-55,5
x
|
-27,5
x
|
-15,7
x
|
-28,8
x
|
-14
x
|
-8,09
x
|
Dividendrendement
|
-
|
-
|
-
|
-
|
-
|
-
|
Marktkapitalisatie/omzet
|
8,45
x
|
5,86
x
|
13,8
x
|
9,71
x
|
5,52
x
|
4,31
x
|
Bedrijfswaarde/omzet
|
6,7
x
|
4,46
x
|
11,1
x
|
8,35
x
|
5,86
x
|
5,2
x
|
Bedrijfswaarde/EBITDA
|
-76,9
x
|
-55,2
x
|
-83,5
x
|
-37,9
x
|
-192
x
|
-11,8
x
|
Bedrijfswaarde/FCF
|
-48,4
x
|
-27,1
x
|
7,61
x
|
-7,81
x
|
-6,4
x
|
-15,7
x
|
FCF Yield
|
-2,06%
|
-3,68%
|
13,1%
|
-12,8%
|
-15,6%
|
-6,37%
|
Price to Book
|
3,03
x
|
2,47
x
|
8,83
x
|
7,89
x
|
4,01
x
|
7,39
x
|
Aantal aandelen (in duizenden)
|
15.717
|
15.717
|
15.717
|
15.869
|
32.870
|
21.410
|
Referentieprijs
2 |
12.000
|
9.050
|
23.200
|
18.500
|
7.770
|
6.770
|
Datum van publicatie
|
21-03-19
|
19-03-20
|
18-03-21
|
17-03-22
|
23-03-23
|
21-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Omzet
1 |
22.317
|
24.284
|
26.358
|
30.240
|
46.293
|
33.657
|
EBITDA
1 |
-1.943
|
-1.962
|
-3.491
|
-6.664
|
-1.413
|
-14.826
|
Bedrijfsresultaat (EBIT)
1 |
-4.021
|
-5.088
|
-6.998
|
-10.550
|
-6.013
|
-19.713
|
Operationele Marge
|
-18,02%
|
-20,95%
|
-26,55%
|
-34,89%
|
-12,99%
|
-58,57%
|
Resultaat voor belastingen (EBT)
1 |
-2.989
|
-3.481
|
-18.011
|
-4.425
|
3.705
|
-17.676
|
Nettowinst (verlies)
1 |
-3.397
|
-5.168
|
-23.187
|
-6.999
|
-2.657
|
-17.672
|
Nettomarge
|
-15,22%
|
-21,28%
|
-87,97%
|
-23,14%
|
-5,74%
|
-52,5%
|
WPA
2 |
-216,1
|
-329,0
|
-1.475
|
-642,5
|
-555,7
|
-837,0
|
Free Cash Flow
1 |
-3.086
|
-3.992
|
38.303
|
-32.330
|
-42.415
|
-11.152
|
FCF-marge
|
-13,83%
|
-16,44%
|
145,32%
|
-106,91%
|
-91,62%
|
-33,13%
|
Kasstroomconversie (ebitda)
|
-
|
-
|
-
|
-
|
-
|
-
|
Kasstroomconversie (nettowinst)
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per aandeel
|
-
|
-
|
-
|
-
|
-
|
-
|
Datum van publicatie
|
21-03-19
|
19-03-20
|
18-03-21
|
17-03-22
|
23-03-23
|
21-03-24
|
Fiscaal tijdperk: december |
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
---|
Nettoschuldpositie
1 |
-
|
-
|
-
|
-
|
15.844
|
30.064
|
Nettokaspositie
1 |
39.134
|
33.906
|
73.327
|
41.109
|
-
|
-
|
Hefboom (schuld/ebitda)
|
-
|
-
|
-
|
-
|
-11,21
x
|
-2,028
x
|
Free Cash Flow
1 |
-3.086
|
-3.992
|
38.303
|
-32.330
|
-42.415
|
-11.152
|
ROE (netto-inkomsten/eigen vermogen)
|
-3,88%
|
-5,74%
|
-31,5%
|
-7,51%
|
1,87%
|
-60,7%
|
ROA (netto-inkomsten/totale activa)
|
-2,79%
|
-3,64%
|
-3,83%
|
-4,72%
|
-3,5%
|
-15,8%
|
Totale activa
1 |
121.632
|
142.126
|
605.726
|
148.226
|
76.014
|
111.624
|
Nettoactief per aandeel
2 |
3.960
|
3.671
|
2.627
|
2.344
|
1.937
|
916,0
|
Cashflow per aandeel
2 |
284,0
|
192,0
|
2.155
|
372,0
|
98,10
|
105,0
|
Capex
1 |
3.062
|
3.815
|
4.997
|
15.043
|
9.078
|
9.174
|
Capex/omzet
|
13,72%
|
15,71%
|
18,96%
|
49,75%
|
19,61%
|
27,26%
|
Datum van publicatie
|
21-03-19
|
19-03-20
|
18-03-21
|
17-03-22
|
23-03-23
|
21-03-24
|
|
Vaira. 1 jan.
|
Kapi.
|
---|
| +65,44% | 161 mln. | | +41,79% | 50,93 mld. | | -0,56% | 42,12 mld. | | +49,62% | 42,05 mld. | | -7,20% | 29,18 mld. | | +12,59% | 26,02 mld. | | -21,51% | 18,9 mld. | | +6,92% | 13,21 mld. | | +24,91% | 12,17 mld. | | +29,60% | 12,16 mld. |
Biotechnologie & Medisch Onderzoek - Andere
|